5月1日 - ** 制药商礼来LLY.N股价盘前下跌4.3%至860.72美元
** 流行减肥药Zepbound的第一季度销售额略低于 (link) 华尔街预期
** Zepbound第一季度的销售额为23.1亿美元，而分析师的平均预期为23.3亿美元，数据由LSEG汇编。
** 公司还将年度每股利润预期从之前的22.5美元至24美元下调至20.78美元至22.28美元之间
** 糖尿病药物 Mounjaro 的销售额为 38.4 亿美元，低于预期的 38.0 亿美元--LSEG
** 截至上次收盘，LLY 年累计上涨 16.4
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.